Pro-inflammatory human Th17 cells selectively express P-glycoprotein and are refractory to glucocorticoids.
about
Immune Cells and Inflammation in Diabetic NephropathyTh1 and Th17 Cells in Tuberculosis: Protection, Pathology, and BiomarkersTranscriptomic Study on Ovine Immune Responses to Fasciola hepatica InfectionLymphocyte roles in metabolic dysfunction: of men and miceBreathing Better Through Bugs: Asthma and the MicrobiomeBCL-2 protects human and mouse Th17 cells from glucocorticoid-induced apoptosisIFN-γ-Producing T-Helper 17.1 Cells Are Increased in Sarcoidosis and Are More Prevalent than T-Helper Type 1 CellsChronic inflammation up-regulates P-gp in peripheral mononuclear blood cells via the STAT3/Nf-κb pathway in 2,4,6-trinitrobenzene sulfonic acid-induced colitis miceCirculating immune cells in multiple sclerosis.Association of the ABCB1 C3435T polymorphism with responsiveness to and toxicity of DMARDs in rheumatoid arthritis : A meta-analysis.Effects of the multidrug resistance-1 gene on drug resistance in primary immune thrombocytopenia.Human Bronchial Epithelial Cells Induce CD141/CD123/DC-SIGN/FLT3 Monocytes That Promote Allogeneic Th17 Differentiation.IL-1β promotes the differentiation of polyfunctional human CCR6+CXCR3+ Th1/17 cells that are specific for pathogenic and commensal microbes.T cell activation and differentiation is modulated by a CD6 domain 1 antibody ItolizumabThe oral commensal Streptococcus mitis shows a mixed memory Th cell signature that is similar to and cross-reactive with Streptococcus pneumoniae.Transcriptional profile of tuberculosis antigen-specific T cells reveals novel multifunctional featuresAutoimmune and autoinflammatory mechanisms in uveitis.IL-17 in severe asthma. Where do we stand?TH17 cells in human recurrent pregnancy loss and pre-eclampsia.CD4+ T cell STAT3 phosphorylation precedes acute GVHD, and subsequent Th17 tissue invasion correlates with GVHD severity and therapeutic response.T cells as a therapeutic target in SLE.Reprogramming antitumor immunityCentral role of IL-17/Th17 immune responses and the gut microbiota in the pathogenesis of intestinal fibrosisGlucocorticoid-resistant Th17 cells are selectively attenuated by cyclosporine A.The impact of ATRA on shaping human myeloid cell responses to epithelial cell-derived stimuli and on T-lymphocyte polarizationLymphocyte migration into atherosclerotic plaque.Functional inflammatory profiles distinguish myelin-reactive T cells from patients with multiple sclerosisEffectiveness and safety of lower dose prednisone for initial treatment of acute graft-versus-host disease: a randomized controlled trial.DNA methylation profiling of the X chromosome reveals an aberrant demethylation on CXCR3 promoter in primary biliary cirrhosisAirway Microbiota in Severe Asthma and Relationship to Asthma Severity and Phenotypes.Time of Initiating Enzyme Replacement Therapy Affects Immune Abnormalities and Disease Severity in Patients with Gaucher Disease.Novel understanding of ABC transporters ABCB1/MDR/P-glycoprotein, ABCC2/MRP2, and ABCG2/BCRP in colorectal pathophysiologyImmune dysfunction in acute alcoholic hepatitis.IL-22, GM-CSF and IL-17 in peripheral CD4+ T cell subpopulations during multiple sclerosis relapses and remission. Impact of corticosteroid therapy.CCR6(+) Th cell populations distinguish ACPA positive from ACPA negative rheumatoid arthritisIdentification of novel HIV-1 dependency factors in primary CCR4(+)CCR6(+)Th17 cells via a genome-wide transcriptional approach.Safety and immunologic effects of high- vs low-dose cholecalciferol in multiple sclerosis.Effects of Systemically Administered Hydrocortisone on the Human Immunome.Urban Particulate Matter-Activated Human Dendritic Cells Induce the Expansion of Potent Inflammatory Th1, Th2, and Th17 Effector Cells.Improving therapy of chronic lymphocytic leukemia with chimeric antigen receptor T cells
P2860
Q26772998-F507DB0B-294C-447E-9793-C3C7D3C83362Q26774207-21DF6A00-504D-4386-AD16-BB14D5CB5483Q27303435-502E1DEB-C6F6-4EE5-A3EA-ABF3503BB13DQ27687298-B68587DA-1D63-48F7-BEAF-932009FD0A19Q28067227-633D89A8-6A0E-4376-BCEF-76BB40FEC277Q28392989-EF415A71-9FC5-4E1F-ACB4-146304CDB574Q28397095-3DC71FB5-99B9-4A5A-9C50-142102AE61C5Q28608251-6C60C348-3437-4FC9-82A0-52150792EDEEQ30242026-A326B1FA-D12A-4794-858B-F3FE7071FD85Q30252113-4292DBC4-1341-450F-9A46-01D3BF1F8359Q33432692-19BCAB07-6656-4A5A-8A71-05BDA7680CC2Q33600149-18253632-7478-4D0D-A22A-2FFAD2F0A061Q33797462-7AF9E5FA-89BF-4B1E-846E-1F8FBF5D04F6Q33865748-9A3E4EAE-6E37-4AE8-8D37-D6008E0280C7Q34041104-8FAE1F1E-4534-435E-9764-61ED688F2579Q34146397-AC8F330D-7874-4FE6-91B3-E758F97C037DQ34294964-2BE3EC5B-F3C7-4571-974E-F554FFD45CA0Q34435370-91132FFC-868F-48DB-BC5E-E19A830413F0Q34455637-AE1ADB51-43E7-406C-B66B-F03AC32F8049Q35207094-72CB59B4-3589-4AD6-B744-CEE8813C77CDQ35214963-3BB610A9-9130-436F-8733-A030A432C1F0Q35216812-69B85F13-27E4-4DF3-BB73-B44A7A2AF62CQ35276739-80467C67-BE31-48E1-80C1-F1B49D7F471DQ35280211-C891AA43-3BA7-4B3B-9A46-9404394BDACDQ35508697-C1CCAFA5-5827-4763-8603-6319E8CD71FCQ35600904-6CD3C1D1-557B-41DF-90DE-C913391A65E8Q35631087-B52BFAE8-542C-4631-BCA3-DB0A91B34032Q35669901-359C1AE8-D307-4B28-97AA-C69F94B5ABC3Q35819281-0AD150D3-B00D-4C0F-B456-57029FC00E04Q35989768-A580207F-FF4C-40D2-8D51-6791DA152486Q36220187-90798579-7A10-42B3-AA01-CC2667D7FD02Q36245600-9CA9C268-2455-416C-99BC-E37F1A9388E6Q36269642-61A33D58-088A-4AA9-933C-DD762D3C526AQ36310557-09623650-C066-4287-ACB3-37A0C4B16112Q36330366-C3AD80F9-6F51-405E-A36E-E070AB10079CQ36364264-FE7AA424-6AFA-4EC8-B69A-D3166C6C2565Q36645164-89FEE413-CF8E-4352-B89F-B8BA777B28BBQ36681995-8432C825-6677-424D-A0A7-13E2DA5ECFF3Q36765939-4ADABE6B-76D1-4D09-8303-C17C5B89FC55Q36777093-6A40698B-A2C6-440A-A02B-FD968618F434
P2860
Pro-inflammatory human Th17 cells selectively express P-glycoprotein and are refractory to glucocorticoids.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 06 January 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Pro-inflammatory human Th17 ce ...... refractory to glucocorticoids.
@en
Pro-inflammatory human Th17 ce ...... refractory to glucocorticoids.
@nl
type
label
Pro-inflammatory human Th17 ce ...... refractory to glucocorticoids.
@en
Pro-inflammatory human Th17 ce ...... refractory to glucocorticoids.
@nl
prefLabel
Pro-inflammatory human Th17 ce ...... refractory to glucocorticoids.
@en
Pro-inflammatory human Th17 ce ...... refractory to glucocorticoids.
@nl
P2093
P2860
P356
P1476
Pro-inflammatory human Th17 ce ...... refractory to glucocorticoids
@en
P2093
Derya Unutmaz
Ivana M Djuretic
Jacob L McCauley
Kelly McKevitt
Lina Kozhaya
Maria A Quintero
Mark S Sundrud
Radha Ramesh
Thaddeus J Carlson
P2860
P304
P356
10.1084/JEM.20130301
P407
P577
2014-01-06T00:00:00Z